Publications
Publication Highlight: Developing a Shared Nomenclature for Radiopharmaceutical Therapy
28th May 2026
Latest news, Events and Press Releases
Find all of our recent press releases, stay updated with the latest news and be informed about upcoming events where Curium will be attending.
Please direct any media inquiries to Camilla Campbell, VP Communications at camilla.campbell@curiumpharma.com.
Publications
News
Curium Partners with Oncidium Foundation to Support Access to Radioligand Therapy
11th May 2026
News
Curium’s GalenVita Ga-68 Generator Wins Red Dot Award for Product Design 2026
17th March 2026
Publications
Publication Alert: Pharmacokinetics and Dosimetry of Lutetium-177 Zadavotide Guraxetan
28th February 2026
Press releases
Curium Announces Pharmacokinetics and Dosimetry Data for Investigational Lutetium-177 Zadavotide Guraxetan in Metastatic Castration-Resistant Prostate Cancer at ASCO GU 2026
26th February 2026
Press releases
Curium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of 177Lu-PSMA-I&T for Prostate Cancer in Japan
4th February 2026
Press releases
Curium’s Investigational New Drug Application Accepted by Center for Drug Evaluation in China
7th January 2026
Events
Curium is attending these global congresses in 2026
23rd December 2025
Press releases
Curium Announces First Commercial Doses of PYLCLARI® for Patients with Prostate Cancer in Poland
23rd December 2025
Press releases
Curium Establishes Legal Entity in China
3rd December 2025
Press releases
CapVest recapitalizes Curium to accelerate its growth strategy, marking the largest transaction in nuclear medicine globally
20th November 2025
Press releases
Curium Consolidates New Biopharma Business and Sets Up Global Headquarters in Boston, Massachusetts
17th November 2025